Resectable Pancreatic Carcinoma Clinical Trial
Official title:
Integrating Acupuncture Into Postoperative Pain Management in Patients Undergoing Open Abdominal Operations
This trial investigates how well acupuncture works for the management of pain after surgery in patients having open colorectal or pancreatic surgery. Acupuncture may help to reduce postoperative symptoms including pain. This study may help researchers learn if acupuncture reduces after-surgery side effects and improves recovery.
PRIMARY OBJECTIVE: I. Determine the feasibility of providing postoperative acupuncture for patients undergoing open colorectal or pancreatic surgery. SECONDARY OBJECTIVE: I. Compare postoperative opioid use for pain management, pain levels, and satisfaction of pain control between acupuncture and standard care groups. EXPLORATORY OBJECTIVE: I. Compare dietary recovery and postoperative length of stay between acupuncture and standard care groups. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (ACUPUNCTURE): Beginning the day after surgery, patients undergo acupuncture sessions over 25 minutes once daily (QD) for up to 7 days. Patients also undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits. ARM II (USUAL CARE): Patients undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01959672 -
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
|
Phase 2 | |
| Terminated |
NCT01333124 -
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
|
Phase 2 | |
| Recruiting |
NCT04858334 -
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
|
Phase 2 | |
| Completed |
NCT02562716 -
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
|
Phase 2 | |
| Completed |
NCT02427841 -
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
|
Phase 2 | |
| Completed |
NCT03823144 -
Intravital Microscopy in Human Solid Tumors
|
N/A | |
| Completed |
NCT02930902 -
Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery
|
Phase 1 | |
| Completed |
NCT03373188 -
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
|
Phase 1 | |
| Recruiting |
NCT05841706 -
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
|
Early Phase 1 |